Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron Effect on BAT in South Asian and Caucasian Men
NCT03012113Phase 4Unknown
- Sponsor
- Ingrid Jazet
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in obesity, type 2 diabetes mellitus (T2DM), sponsored by Ingrid Jazet. Status: unknown.
02
Drugs
mirabegron
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03012113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012113.